Drug firm Indoco Remedies Wednesday said the US health regulator has issued four observations after inspection of its manufacturing facility in Goa.
"The US Food and Drug Administration (USFDA) conducted audit at Indoco's sterile manufacturing facility in Verna, Goa (Plant II) from May 27 to June 4, 2019, issuing 4 observations (483s)," the company said in a filing to BSE.
These observations are procedural in nature, not pertaining to data integrity, it added.
The company did not disclose the details of the observations made by the regulator but said it will submit its response shortly.
"The recent USFDA inspection was a scheduled Prior Approval Inspection for injectable products, filed from this facility. We are hopeful for an early and successful closure of this audit, which will expedite approvals of the pending abbreviated new drug applications (ANDAs)," MD Aditi Kare Panandikar said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app